Moderna Income from Continuous Operations 2017-2024 | MRNA
Moderna income from continuous operations for the twelve months ending December 31, 2024 was $-3.561B, a 24.46% decline year-over-year.
- Moderna annual income from continuous operations for 2024 was $-3.561B, a 24.46% decline from 2023.
- Moderna annual income from continuous operations for 2023 was $-4.714B, a 156.37% decline from 2022.
- Moderna annual income from continuous operations for 2022 was $8.362B, a 31.47% decline from 2021.